Skin Analytics, a U.K.-based startup that has developed a skin cancer screening service that uses artificial intelligence, has raised £4 million in Series A funding. The round was led by Hoxton ...

As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...

The UK’s National Health Service (NHS) has published a report showing that Skin Analytics’ AI tool DERM could be used to assess images of lesions for skin cancer. The report reviewed Skin Analytics’ ...

Skin Analytics, an AI medical technology company, has been granted a Phase 4 AI in Health and Care Award by NHSX. Created to accelerate the evaluation of Artificial Intelligence (AI) technologies ...

THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including ...

(MENAFN- GlobeNewsWire - Nasdaq) THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea , a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi ...

A British health technology company which uses AI to conduct skin cancer tests within five minutes has landed £15m in a funding round led by a leading global financier. Sky News has learnt that Skin ...

Skin Analytics Receives Class IIA UKCA Mark for AI-based Skin Cancer Tool that Supports Dermatology Capacity in the NHS Skin Analytics secures UKCA mark for DERM, its AI skin cancer tool, a first in ...